CDKN2A and Barrett esophagus: Likewise, Wang et al. demonstrated that BE patients who advanced from baseline pathology to HGD or EAC exhibited a markedly higher prevalence of CDKN2A hypermethylation in their initial biopsies compared with non-progressors as measured by sodium bisulfite conversion followed by MSP [130].